Amino acid sequence of the predominant basic protein in human seminal plasma  by Lilja, H. & Jeppsson, J.-O.
Volume 182, number 1 FEBS 2334 March 1985 
Amino acid sequence of the predominant basic protein in 
human seminal plasma 
H. Lilja and J.-O. Jeppsson 
Department of Clinical Chemistry, University of Lund, Malm6 General Hospital, S-214 01 Malmii, Sweden 
Received 29 October 1984 
The predominant basic protein in liquefied human seminal plasma is the major degradation product of the 
gel-forming protein secreted by the seminal vesicles. The amino acid sequence of this basic protein is present- 
ed. The basic protein contains 52 amino acid residues. It is devoid of cysteine, methionine, tryptophan, and 
leucine, but contains seven histidine residues located in the NH,-terminal half of the molecule. The calculat- 
ed M,of 5753 is in close agreement with that obtained from gel filtration in guanidine-HCI on Sephacryl 
S-200 (M, = 6000). 
Amino acid sequence Inhibin Seminal plasma Seminal vesicle 
1. INTRODUCTION 2. MATERIALS AND METHODS 
The coagulate structure of freshly ejaculated 
semen is liquefied within 15 min by prostatic en- 
zyme(s) [l]. It has been proposed that the protein 
predominant in seminal vesicle secretion is the 
structural protein of the coagulate [2], and that 
during liquefaction this protein is cleaved into a 
number of basic proteins, the major one of which 
has recently been purified [3]. As estimated using 
SDS-polyacrylamide gel electrophoresis (SDS- 
PAGE), the protein’s n/l, is about 12800. Its 
NHz-terminal sequence, comprising 3 1 identified 
amino acid residues, is unique according to the 
Dayhoff data base [3]. Seidah et al. [4] recently 
presented an identical NHz-terminal sequence of a 
basic peptide, also purified from human seminal 
plasma and consisting of about 35 amino acid 
residues, and which was found to inhibit secretion 
of rat pituitary follicle-stimulating hormone. A 
synthetic replica of this NHZ-terminal sequence has 
been shown to have a similar inhibitory capacity 
[5]. Here, we report the complete sequence of the 
predominant basic protein in human seminal 
plasma. 
2.1. Chemicals, separation materials, and 
enzymes 
Sephacryl@ S-200 and FPLC@ system equip- 
ped with an HR 5/5 PepRPC(Cz/Cis) column 
were from Pharmacia (Uppsala); Ultropac@ 
TSK G 2000 SW column from LKB (Bromma, 
Sweden); diisopropylfluorophosphate (DFP) from 
Sigma (St Louis, MO); trypsin treated with L- 
(tosylamide-2-phenyl)ethyl chloromethyl ketone 
(TPCK) from Worthington (Freehold, NJ). Car- 
boxypeptidase Y was a gift to Professor J. Stenflo 
from Professor M. Ottesen, Carlsberg Labora- 
tories (Copenhagen, Denmark). 
2.2. Sample, material, purifications, preparation 
of fragments, and COOH-terminal analysis 
The predominant basic protein was purified 
from pooled human seminal plasma as in [3]. 
Lysine-blocked protein was prepared by treatment 
with citraconic anhydride (30 mol/mol purified 
protein) according to Atassi and Habeeb [6]. Tryp- 
tic digestion of intact or lysine-blocked protein 
(3 mg/ml) in 0.1 M NH4HCO3 was carried out at 
37°C for 3 h, at an enzyme:substrate ratio of 
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1 :20. TPCK-trypsin was inactivated by DFP 
(20 mM). The digestion products of the lysine- 
blocked protein were kept at pH 4 for 3 h at 37°C 
to deblock the amino groups before separation. 
Fragments obtained were purified by reversed- 
phase chromatography (RPC) as described in the 
legend to fig..2. Intact protein or isolated 
fragments were digested with carboxypeptidase Y 
[7] as described in the legend to fig.3. 
2.3. M, estimation of purified predominant basic 
protein 
Reduced and carboxymethylated proteins were 
gel filtered on a Sephacryl S-200 column (1749 x 
16 mm) equilibrated in 0.25 M sodium phosphate 
with 6 M guanidine-HCl, pH 7.4 [8]. HPLC gel 
filtration in 0.1 M sodium phosphate with 6 M 
guanidine-HCl, pH 6.9, was performed in a TSK 
G 2000 SW column at a flow rate of 0.5 ml/min. 
2.4. Amino acid analysis 
Amino acid analysis was performed on a 
Beckman 119 CL analyser after hydrolysis of 
fragments in 6 M HCl at 110°C for 24 h [9]. 
Hydrolysis in 4 M methanesulphonic acid for tryp- 
tophan analysis was performed according to Inglis 
[lOI. 
2.5. Sequence determination 
Sequence determination by automatic Edman 
degradations was performed in a Beckman 890 C 
sequencer. The Beckman no.127974 Quadrol pro- 
gram was used and 2 mg polybrene was added to 
the spinning cup. PTH amino acids were identified 
by HPLC [ll]. 
3. RESULTS 
3.1. NHz-terminal sequence degradation of intact 
protein 
Automatic Edman degradations of the intact 
protein (20 and 90 nmol) allowed identification of 
31 NHz-terminal residues and separate residues to 
position 45 (fig. 1). 
3.2. Tryptic fragments 
Tryptic fragments were purified by RPC 
(fig.2a). Fragments TRO-TR4 were hydrolysed 
and amino acid analysis showed an equal molar 
yield for all fragments (65% of theoretical yield). 
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Fig.1. Amino acid sequence of the predominant basic 
protein in human seminal plasma. The sequence is 
presented in the standard IUPAC, one-letter code for 
amino acid residues. The numbering of tryptic 
fragments (TRI-TR4) and the numbering of fragments 
of lysine-blocked protein (ARGI-ARG4) are explained 
in fig.2. (0) Residues identified by sequenator analysis; 
(0) residues not identified by sequenator analysis; (-_) 
residues identified by carboxypeptidase Y digestion. 
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Fig.2. Reversed-phase chromatography on an HR 5/5 
Pep RPC (CZ/CIE) column at a flow rate of 0.5 ml/min. 
Elution was performed with a 80 min gradient from 0 to 
25% B, or from 0 to 75% B; solvent A, 0.1% (v/v) 
trifluoroacetic acid in water; solvent B, 80% (v/v) 
acetonitrile-0.1% (v/v) trifluoroacetic acid; (A) TR 
fragments obtained from tryptic digestion of intact 
protein; (B) ARC fragments obtained from tryptic 
digestion of lysine-blocked protein. 
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The molar ratios of the amino acids in TRO cor- 
responded to those of the residues constituting 
position l-11 plus 25-30 (fig.1). Sequenator 
analysis of TRl, TR2, and TR4 allowed identifica- 
tion of all residues. Ten NHz-terminal residues in 
TR3 were identified by sequenator analysis. 
3.3. Fragments of lysine-blocked protein 
Fragments obtained by tryptic digestion of 
citraconylated protein were purified by RPC 
(fig.2b). ARGO contained no amino acids. 
ARGl-ARG4 fragments were obtained in equal 
molar yields (50% of theoretic yield). Amino acid 
analysis of ARGl, ARG2a, ARG2b, and ARG3 
allowed their identification (fig.1). Sequenator 
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Fig.3. Liberated amino acids after digestion of intact 
protein with carboxypeptidase Y at an enzyme: substrate 
ratio of 1: 30 or 2 : 30. Digestion was performed in 0.1 M 
pyridine-acetate, pH 5.5, at 37°C. Reaction was stopped 
by adding equal volume of 6% (w/v) sulphosalicylic acid 
to the vial which was then immediately placed in boiling 
water and then centrifuged. The separated supernatant 
was analysed on a Beckman 6300 amino acid analyser; 
(A) 8 nmol of intact protein digested for O-12 min; (B) 
6 nmol of protein digested for O-120 min. 
analysis of ARG4a (15 nmol) allowed identifica- 
tion of all residues except hose at positions 13 and 
20. The coinciding results from amino acid 
analysis of ARG4a, ARG4b, and ARG4c were 
consistent with the presence of proline and serine 
in these positions (fig.1). Carboxypeptidase Y 
digestion liberated tyrosine as the COOH-terminal 
residue from ARG4a, 4b, and 4c. 
3.4. COOH-terminal analysis of intact protein 
COOH-terminal residues were identified by 
following the release of amino acids during car- 
boxypeptidase Y digestion of intact protein (fig.3a 
and b). 
3 S. M, estimation of purified predominant basic 
protein 
Gel filtration in 6 M guanidine-HCl on 
Sephacryl S-200 gave the purified protein an M, of 
6000 (not shown). The protein eluted, however, in 
two distinct peaks from a TSKG 2000 SW column 
equilibrated in 6 M guanidine-HCl (not shown). 
Table 1 
Amino acid composition of the purified predominant 
basic protein 
Amino acid 
Aspartic acid 
Threonine 
Serine 
Glutamic acid 
Proline 
Giycine 
Alanine 
Valine 
Isoleucine 
Tyrosine 
Phenylalanine 
Lysine 
Histidine 
Arginine 
nmol/ Residue/ Sequence 
sample mol 
229.9 6.3 6 
38.6 1.1 1 
198.1 5.4 6 
228.6 6.2 6 
76.7 2.1 2 
298.3 8.1 8 
39.9 1.1 1 
48.4 1.3 2 
67.6 1.8 2 
34.2 0.9 1 
41.2 1.1 1 
223.5 6.1 6 
269.2 7.3 7 
116.5 3.2 3 
Total 1910.7 52 
43Opg of intact protein was hydrolysed in 4 M 
methanesulphonic acid at 110°C for 24 h. Hydrolysate 
was analysed on the Beckman 6300 analyser. No 
tryptophan was found in the sample 
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The first peak eluted with the same retention as 
carboxymethylated cytochrome c (Mr = 12800), 
and the second peak eluted with the same retention 
as carboxymethylated aprotinin (Mr = 6400). 
3.6. Complete amino acid sequence of the 
predominant basic protein in seminal plasma 
The amino acid residues identified by 
NHz-terminal analysis in intact protein provide 
considerable overlap into ARG4. The position of 
TR4 as the COOH-terminal fragment is well 
substantiated. The heterogeneity of ARG4 
fragments might be explained by deamidation of 
glutamine residues. All peptides isolated are con- 
sistent with the sequence deduced (fig.1). Amino 
acid analysis of the intact protein after hydrolysis 
in 4 M methanesulphonic acid (table 1) agrees 
closely with the sequence presented. The protein 
contains 52 amino acid residues, from which its M, 
is calculated to be 5753. 
4. DISCUSSION 
The calculated Mr (5753) of the predominant 
basic protein is in close agreement with that ob- 
tained by gel filtration on Sephacryl S-200 in 6 M 
guanidine-HCl. Analysis with SDS-PAGE has 
previously given the protein an M, of 12800, and 
HPLC gel filtration in 0.1 M ammonium acetate at 
pH 5.5 an A4, of 15000 [3]. Upon HPLC gel filtra- 
tion in 6 M guanidine-HCl, the purified protein 
eluted in two peaks, the first of which eluted at a 
position corresponding to twice the A4, of the pro- 
tein sequence. These data suggest he existence of 
a dimeric form of the purified protein which is 
remarkably stable under denaturing conditions. 
According to the Protein Sequence Database of 
the Protein Identification Resource (Washington, 
DC), the sequenced protein has a 47% identity 
with a histidine-rich portion of the bovine type I 
precursor of high-M, kininogen in an overlap of 17 
amino acid residues. In an overlap of 42 residues, 
the predominant basic protein has a 21% identity 
with the bovine type II precursor of high-Mr 
kininogen. Furthermore the protein has a 30% 
identity with human histone 2A in an overlap of 30 
residues, and a 34% identity with DNA-dependent 
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RNA polymerase (EC 2.7.7.6) in an overlap of 29 
residues. The predominant basic protein in seminal 
plasma is a major degradation product of a high- 
A4, precursor secreted by the seminal vesicles [3], 
and is very labile in seminal plasma [ 121. Seidah et 
al. [4] have purified and partly characterised an 
inhibin-like basic peptide, whose NHz-terminal se- 
quence is identical with that presented here, and 
which is considered to be a degradation product of 
the predominant basic protein in seminal plasma. 
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